El-Nile Co. for Pharmaceuticals & Chemical Industries (NIPH) Financials

Annual financial statement highlights for El-Nile Co. for Pharmaceuticals & Chemical Industries covering fiscal years 2006–2025. Figures are updated weekly.

Fiscal yearRevenueNet incomeEPSFree cash flowTotal assetsTotal debtDividend per share
2025ended Jun 20251.29B125.73M2.79-472.82M2.32B988.73M2.00
2024ended Jun 20241.14B90.23M2.36-155.47M1.47B575.28M2.47
2023ended Jun 20231.01B119.21M3.12-283.95M1.04B212.49M1.32
2022ended Jun 2022876.78M89.67M2.35-43.09M769.38M79.78M0.79
2021ended Jun 2021755.51M64.42M1.6875.18M720.14M43.39M0.53
2020ended Jun 2020812.54M93.38M2.4444.53M679.96M43.87M0.26
2019ended Jun 2019638.27M6.7M0.1870.51M574.73M74.63M0.00
2018ended Jun 2018459.93M-17.59M-0.46-38.04M618.27M86.11M0.00
2017ended Jun 2017417.74M23.19M0.61-5.28M568.87M46.09M0.27
2016ended Jun 2016330.46M8.66M0.23-4.27M421.49M00.12
2015ended Jun 2015287.46M17.92M0.47-5.09M414.69M00.19
2014ended Jun 2014330.08M17.13M0.4531.96M427.29M00.19
2013ended Jun 2013351.69M22.28M0.584.38M449.31M00.29
2012ended Jun 2012342.79M25.31M0.6630.69M456.29M00.34
2011ended Jun 2011337.81M48.09M1.2622.52M453.77M00.65
2010ended Jun 2010341.46M61.31M1.6048.8M430.44M00.00
2009ended Jun 2009331.61M55.04M1.44-3.31M402.29M00.78
2008ended Jun 2008316.77M54.26M1.4241.43M372.97M00.24
2007ended Jun 2007333.74M50.78M1.3322.61M344.32M90,0000.72
2006ended Jun 2006304.16M45.96M0.8057.51M321.39M1.5M0.26

All figures in EGP, as reported in the company’s annual results; updated weekly.